Descripción del proyecto
Dispositivo vestible de próxima generación para atletas
Los dispositivos de salud vestible son una tecnología emergente que está cambiando el enfoque de la supervisión de la salud. Los sensores vestibles nos permiten realizar un seguimiento de la salud y gestionarla de forma proactiva, por lo que los atletas también están comenzando a usarlos para supervisar su rendimiento, lesiones y tiempo de recuperación. El proyecto financiado con fondos europeos Smart Tracker comercializará el Caura pack, el primer dispositivo de seguimiento molecular que mide en tiempo real la concentración de lactato y glucosa para determinar la firma molecular del organismo. Para los atletas, proporciona información valiosa sobre cómo se está comportando su cuerpo para evitar el agotamiento durante el entrenamiento. La monitorización no invasiva, inalámbrica y continua de la glucosa y el lactato ayuda a los atletas a identificar qué dieta funciona mejor y cuál es el momento óptimo para entrenarse. El Caura pack utiliza la nueva tecnología de microaguja, un dispositivo de seguimiento rentable y sofisticados algoritmos de aprendizaje automático.
Objetivo
Wearable biosensor systems for fitness and health monitoring have become popular in the last years, however, there is no
wearable technology currently available for accurately monitor key biometrics that directly reflect one’s body performance
(i.e. glucose and lactate) with clinical precision. In turn, Caura project aims at providing the first molecular tracker which
unlocks anyone’s molecular signature. It will give instant and real-time feedback on lifestyle and health, while providing
unmatched training insights and effective dietary plans through non-invasive, wireless and continuous glucose and lactate
monitoring. The invention relies on their cutting-edge microneedle technology, a cost-effective digital tracker plus
sophisticated machine learning algorithms allowing accurate and real-time glucose and lactate measurements for the first
time on the individual’s skin and under free living conditions. Caura will result on added value for high-quality wearables,
improving athletic performance and sport medicine by enabling ubiquitous monitoring of those biometrics. Other valuable
novelties are its reduced cost and dimensions compared to the available options. These advantages make Caura a
disruptive solution with great potential for commercial success in the growing wearables market (€285B by 2022, CAGR
12.5%), representing a core source of growth for the company and consolidating the Company position in the bio-sensing
sector. The Company will conduct a feasibility study and a business plan analyzing the technical, commercial and financial
aspects required to ensure the market launch. Being glucose and lactate important vital parameters also involved in some of
the biggest health issues (e.g. diabetes, obesity etc.), Caura will transition from simple recreational tracker to life-changing
tool focusing on individual’s lifestyle and health, enabling for the necessary transformation towards a person-centred
preventive health care system.
Ámbito científico
- engineering and technologyelectrical engineering, electronic engineering, information engineeringelectronic engineeringsensorsbiosensors
- natural sciencescomputer and information sciencesinternetinternet of things
- social scienceseconomics and businessbusiness and managementbusiness models
- natural sciencescomputer and information sciencesartificial intelligencemachine learning
- medical and health scienceshealth sciencesnutritionobesity
Programa(s)
Convocatoria de propuestas
Consulte otros proyectos de esta convocatoriaConvocatoria de subcontratación
H2020-SMEInst-2018-2020-1
Régimen de financiación
SME-1 - SME instrument phase 1Coordinador
SW1P 2QW LONDON
Reino Unido
Organización definida por ella misma como pequeña y mediana empresa (pyme) en el momento de la firma del acuerdo de subvención.